Understand how we invest.
Apply for funding and upload information.
Find talent. Enter the Council workspace.
Meet our team. View our porfolio.
UT Horizon Fund portfolio company, Decisio Health, is recognized as a finalist for the Fierce Innovation Awards: Healthcare Edition.
Apollo Endosurgery, a UT Horizon Fund Portfolio Company, aims to expand definition of digestive treatments.
UT Horizon Fund Portfolio Company, MicroTransponder, developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains.
Aeglea BioTherapeutics, UT Horizon Fund Portfolio Company, announces IND application approval.
Learn how #UTHorizonFund company @Microtranspondr's Vivitism System is impacting this patient's #stroke rehab! #VNS https://t.co/SssKKnauU5
#UTHorizonFund company & @UTSA #startup Cardiovate receives investment from TRTF today at the San Antonio Emerging… https://t.co/XC8yTMmKU1